GlobalData underscores the urgent need for affordable biosimilars to meet the demands of a growing number of HER2+ breast cancer patients
The ongoing legal battle...
Luis MartÃn Lázaro discusses LUDA's unique business model, the rationale behind its expansion plans in the UK, and its future aspirationsÂ
“There is a culture...
People are warned that use of unbranded devices could exacerbate the situation by pushing obstructions further down into the airway passageÂ
The Medicines and Healthcare...